Show/hide main menu



preparing-x-ray430x176Our research programmes

There are 13 research programmes and 20 research groups in the Comprehensice Cancer Centre. You can find out more about the work of each of the programmes using the links below.

Our research groups

Research strategy

The overarching objective of the Comprehensive Cancer Centre is to combine research excellence with innovations in clinical practice to improve cancer patient care. Our ability to deliver on this objective has been the subject of extensive planning, with members of the Centre working with our associated NHS Trusts and the South-East London Cancer Network to assess what delivers a world class cancer research and care environment.

The Research and Development component of our joint King's College London and NHS Trusts' plan is driven by Professor Parker and Professor Purushotham, under the umbrella of the King's Health Partners Comprehensive Cancer Centre, in liaison with colleagues across the Centre.

By fostering a culture of innovation in cancer patient care, we aim to break down traditional clinical and academic boundaries to achieve a fully integrated cancer research pathway. This is reflected in the coordinated strategic planning that provides the foundations for our Comprehensive Cancer Centre.

Translational research

Molecular understanding with the associated therapeutic and prognostic insights, directly underpins progression towards individualised patient care. Linked to this will be an ever increasing demand for patient choice and the need to provide alternatives for some patients where best practice treatments are ineffective. Choice will come not only in the form of ongoing clinical trials options, but also through palliative care programmes designed to optimise quality of life. Developing these and rigorously quantifying benefits for patients are the key areas of work for the Cenre.

The Centre continues to foster and develop its strengths in epidemiology, palliative care and molecular cancer cell biology with an emphasis in haematopoietic and breast oncology.

Sitemap Site help Terms and conditions  Privacy policy  Accessibility  Modern slavery statement  Contact us

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454